Annual ROE:
435.49%+299.27%(+219.70%)Summary
- As of today, CYTK annual return on equity is 435.49%, with the most recent change of +299.27% (+219.70%) on December 31, 2024.
- During the last 3 years, CYTK annual ROE has risen by +556.03% (+461.28%).
- CYTK annual ROE is now at all-time high.
Performance
CYTK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
309.18%-492.08%(-61.41%)Summary
- As of today, CYTK quarterly return on equity is 309.18%, with the most recent change of -492.08% (-61.41%) on June 30, 2025.
- Over the past year, CYTK quarterly ROE has increased by +113.17% (+57.74%).
- CYTK quarterly ROE is now -79.46% below its all-time high of 1505.62%, reached on December 31, 2019.
Performance
CYTK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CYTK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +219.7% | +57.7% |
| 3Y3 Years | +461.3% | +311.1% |
| 5Y5 Years | +126.8% | -14.9% |
CYTK ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +176.1% | -61.4% | +155.3% |
| 5Y | 5-Year | at high | +126.8% | -61.4% | +110.1% |
| All-Time | All-Time | at high | +126.8% | -79.5% | +110.1% |
CYTK ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | 309.18%(-61.4%) |
| Mar 2025 | - | 801.26%(+48.5%) |
| Dec 2024 | 435.49%(+219.7%) | 539.74%(+61.0%) |
| Sep 2024 | - | 335.19%(+71.0%) |
| Jun 2024 | - | 196.01%(+43.6%) |
| Mar 2024 | - | 136.54%(-10.0%) |
| Dec 2023 | 136.22%(+123.8%) | 151.74%(-20.1%) |
| Sep 2023 | - | 190.01%(-39.6%) |
| Jun 2023 | - | 314.64%(-55.9%) |
| Mar 2023 | - | 713.59%(+227.6%) |
| Dec 2022 | -572.15%(-374.7%) | -559.39%(-179.4%) |
| Sep 2022 | - | -200.22%(-36.7%) |
| Jun 2022 | - | -146.48%(+21.1%) |
| Mar 2022 | - | -185.77%(-19.2%) |
| Dec 2021 | -120.54%(+51.5%) | -155.89%(+18.7%) |
| Sep 2021 | - | -191.73%(+33.7%) |
| Jun 2021 | - | -289.26%(+11.3%) |
| Mar 2021 | - | -325.99%(+34.3%) |
| Dec 2020 | -248.50%(+84.7%) | -496.22%(+83.8%) |
| Sep 2020 | - | -3065.13%(-943.8%) |
| Jun 2020 | - | 363.26%(-43.9%) |
| Mar 2020 | - | 647.22%(-57.0%) |
| Dec 2019 | -1622.88%(-936.5%) | 1505.62%(+245.1%) |
| Sep 2019 | - | -1037.99%(-186.3%) |
| Jun 2019 | - | -362.56%(-76.3%) |
| Mar 2019 | - | -205.69%(-40.3%) |
| Dec 2018 | -156.57%(-25.1%) | -146.56%(-17.9%) |
| Sep 2018 | - | -124.35%(-15.5%) |
| Jun 2018 | - | -107.68%(-2.1%) |
| Mar 2018 | - | -105.45%(-2.6%) |
| Dec 2017 | -125.16%(-719.9%) | -102.79%(-53.0%) |
| Sep 2017 | - | -67.18%(-364.0%) |
| Jun 2017 | - | -14.48%(-462.9%) |
| Mar 2017 | - | 3.99%(-82.8%) |
| Dec 2016 | 20.19%(+143.2%) | 23.22%(>+9900.0%) |
| Sep 2016 | - | 0.10%(+100.2%) |
| Jun 2016 | - | -66.39%(-14.0%) |
| Mar 2016 | - | -58.22%(-20.1%) |
| Dec 2015 | -46.69%(-133.6%) | -48.46%(-91.6%) |
| Sep 2015 | - | -25.29%(-20.4%) |
| Jun 2015 | - | -21.01%(-18.0%) |
| Mar 2015 | - | -17.81%(+6.4%) |
| Dec 2014 | -19.99% | -19.02%(+23.6%) |
| Sep 2014 | - | -24.88%(+33.2%) |
| Jun 2014 | - | -37.25%(+27.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -51.31%(+16.4%) |
| Dec 2013 | -54.15%(+20.7%) | -61.37%(+28.6%) |
| Sep 2013 | - | -85.93%(-22.7%) |
| Jun 2013 | - | -70.01%(-10.9%) |
| Mar 2013 | - | -63.12%(-3.5%) |
| Dec 2012 | -68.27%(+15.3%) | -61.01%(+5.0%) |
| Sep 2012 | - | -64.24%(+5.8%) |
| Jun 2012 | - | -68.17%(+19.2%) |
| Mar 2012 | - | -84.34%(-6.3%) |
| Dec 2011 | -80.64%(-40.7%) | -79.33%(-9.9%) |
| Sep 2011 | - | -72.20%(-5.5%) |
| Jun 2011 | - | -68.45%(-8.6%) |
| Mar 2011 | - | -63.04%(-9.7%) |
| Dec 2010 | -57.33%(-276.6%) | -57.45%(-7.7%) |
| Sep 2010 | - | -53.32%(-18.9%) |
| Jun 2010 | - | -44.83%(-284.3%) |
| Mar 2010 | - | 24.32%(-14.8%) |
| Dec 2009 | 32.47%(+143.1%) | 28.55%(-16.0%) |
| Sep 2009 | - | 33.99%(+29.5%) |
| Jun 2009 | - | 26.25%(+131.0%) |
| Mar 2009 | - | -84.80%(-10.2%) |
| Dec 2008 | -75.33%(-58.9%) | -76.97%(-11.6%) |
| Sep 2008 | - | -68.99%(-23.0%) |
| Jun 2008 | - | -56.08%(-16.2%) |
| Mar 2008 | - | -48.27%(-8.4%) |
| Dec 2007 | -47.42%(+25.3%) | -44.53%(+7.7%) |
| Sep 2007 | - | -48.24%(+9.4%) |
| Jun 2007 | - | -53.27%(+4.4%) |
| Mar 2007 | - | -55.71%(+10.8%) |
| Dec 2006 | -63.51%(-36.1%) | -62.45%(-2.6%) |
| Sep 2006 | - | -60.87%(-10.8%) |
| Jun 2006 | - | -54.96%(-8.5%) |
| Mar 2006 | - | -50.64%(-6.6%) |
| Dec 2005 | -46.66%(-48.8%) | -47.50%(-8.2%) |
| Sep 2005 | - | -43.91%(-9.9%) |
| Jun 2005 | - | -39.96%(+6.8%) |
| Mar 2005 | - | -42.88%(-12.3%) |
| Dec 2004 | -31.36%(+22.1%) | -38.17%(+83.8%) |
| Sep 2004 | - | -235.30%(-78.8%) |
| Jun 2004 | - | -131.58%(-223.2%) |
| Mar 2004 | - | 106.81%(+215.0%) |
| Dec 2003 | -40.25%(+22.7%) | 33.91% |
| Dec 2002 | -52.06%(-86.3%) | - |
| Dec 2001 | -27.95%(-23.2%) | - |
| Dec 2000 | -22.69% | - |
FAQ
- What is Cytokinetics, Incorporated annual return on equity?
- What is the all-time high annual ROE for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual ROE year-on-year change?
- What is Cytokinetics, Incorporated quarterly return on equity?
- What is the all-time high quarterly ROE for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly ROE year-on-year change?
What is Cytokinetics, Incorporated annual return on equity?
The current annual ROE of CYTK is 435.49%
What is the all-time high annual ROE for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual return on equity is 435.49%
What is Cytokinetics, Incorporated annual ROE year-on-year change?
Over the past year, CYTK annual return on equity has changed by +299.27% (+219.70%)
What is Cytokinetics, Incorporated quarterly return on equity?
The current quarterly ROE of CYTK is 309.18%
What is the all-time high quarterly ROE for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly return on equity is 1505.62%
What is Cytokinetics, Incorporated quarterly ROE year-on-year change?
Over the past year, CYTK quarterly return on equity has changed by +113.17% (+57.74%)